LONDON (Alliance News) - GlaxoSmithKline PLC will this week announce plans to launch late stage clinical trials on ten new drugs over the next two years, the Daily Telegraph reported Monday, without saying where it got the information.
The list will include medicines in Glaxo?s key areas of cancer and respiratory disease, the paper says it understands. These drugs have never been detailed to investors before, since Glaxo does not publish information on drugs in early development, it added.
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10608496/GSK-seeks-to-move-on-from-China-with-pipeline-update.html
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Glaxosmithkline (GSK)